IP Library › Granted Patent US 10,036,016
Granted Patent B2
US 10,036,016 · App. 15/021,495 · Granted Jul 31, 2018

Methods for inducing glucose uptake

Inventors: Shenhav Cohen (Raanana, IL); Alfred L. Goldberg (Boston, MA)
Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
C12N15/113A61K31/7115A61K38/1709C07K16/18C12N2310/15C12N2310/531
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,036,016
App. No.
15/021,495
Granted
Jul 31, 2018
Kind
B2
Abstract

The present invention provides a method for inducing glucose uptake in a muscle cell by inhibiting Trim32 protein in the cell and to a method for inducing glucose uptake in a muscle cell, by increasing the abundance of plakoglobin protein in the cell.

Claims (18)

1. A method for inducing glucose uptake in a muscle cell in a subject suffering from insulin resistance, comprising the step of inhibiting Trim32 protein in said cell in the subject suffering from insulin resistance, thereby inducing glucose uptake in a muscle cell in the subject suffering from insulin resistance.

2. The method of claim 1 , wherein said muscle cell is a skeletal muscle cell.

3. The method of claim 1 , wherein said inhibiting Trim32 in said cell is further inducing muscle fiber growth.

4. The method of claim 1 , wherein said inhibiting Trim32 in said cell is inducing the phosphorylation of insulin receptor in said cell.

5. The method of claim 1 , wherein said inhibiting Trim32 is inducing the accumulation of plakoglobin.

6. The method of claim 1 , wherein said inhibiting Trim32 in said cell is expressing a dominant negative Trim 32 protein in said cell.

7. The method of claim 6 , wherein said expressing a dominant negative Trim 32 protein in said cell is inserting a synthetic mRNA molecule encoding said dominant negative Trim 32 protein into said cell, said synthetic mRNA molecule comprises a 5-methylcytidine base, a pseudouridine base, or a combination thereof.

8. The method of claim 6 , wherein said expressing a dominant negative Trim 32 protein in said cell is delivering a nucleic acid molecule encoding said dominant negative Trim 32 protein via electroporation into said cell.

9. The method of claim 6 , wherein said expressing a dominant negative Trim 32 protein in said cell is delivering a nucleic acid molecule encoding said dominant negative Trim 32 protein via a cationic vector into said cell.

10. A method for inducing glucose uptake in a muscle cell in a subject suffering from insulin resistance, comprising the step of increasing the abundance of plakoglobin protein in said cell, thereby inducing glucose uptake in a muscle cell in the subject suffering from insulin resistance.

11. The method of claim 10 , wherein said muscle cell is a skeletal muscle cell.

12. The method of claim 10 , wherein said increasing the abundance of plakoglobin protein in said cell further results in inducing muscle fiber growth.

13. The method of claim 10 , wherein said increasing the abundance of plakoglobin protein in said cell results in inducing the phosphorylation of insulin receptor in said cell.

14. The method of claim 10 , wherein said increasing the abundance of plakoglobin protein in said cell is transfecting said cell with a vector comprising a nucleic acid molecule, said nucleic acid molecule encodes said plakoglobin protein.

15. The method of claim 14 , wherein said vector comprises a constitutively active promoter.

16. The method of claim 14 , wherein said nucleic acid molecule is a synthetic mRNA molecule comprising a 5-methylcytidine base, a pseudouridine base, or a combination thereof.

17. The method of claim 14 , wherein said transfecting said cell is via electroporation into said cell.

18. The method of claim 14 , wherein said vector is a cationic vector.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2018
From: COHEN, SHENHAV; GOLDBERG, ALFRED L.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 045106/0650 →
Continuity (2)
Provisional Application 61876929 · Sep 12, 2013
Related Publication 20160230171A1 · Aug 11, 2016
Cited By (2)
US 12,576,161 US 12,630,841